Diabetes

Results of analysis emphasize importance of developing effective means of preventing or treating obesity in youth.

Symposium on PCSK9 inhibitors in treatment of type 1 diabetes highlighted at 77th Scientific Sessions of the ADA.

Tresiba found to offer patients with type 2 diabetes (T2D) a lower risk of severe hypoglycemia.

Research of macrovascular complications in diabetes honored at American Diabetes Association’s 77th Scientific Sessions.

Gernot Desoye, PhD, was chosen to receive the American Diabetes Association (ADA) 2017 Norbert Freinkel Award, which honors the memory of Norbert Freinkel, who was a talented researcher and writer.

Michael A. Harris, PhD, has been awarded with the American Diabetes Association (ADA) 2017 Richard R. Rubin Award, which recognizes a researcher who has made significant contributions to understanding the behavioral components of diabetes treatment.

The enzyme that affects the body's ability to process LDL cholesterol was found to be correlated with A1C levels. A symposium on the topic will be part of this weekend's 77th Scientific Sessions of the American Diabetes Association.

BioChaperone platform could increase the efficacy and safety of diabetes drugs.

Research of macrovascular complications in diabetes honored at American Diabetes Association’s 77th Scientific Sessions.

Researcher awarded for improving the understanding of diabetes during pregnancy.

Type 1 diabetes researcher awarded at American Diabetes Association’s 77th Scientific Sessions.

Manufacturers to present data from studies of diabetes drugs at American Diabetes Association 77th Scientific Sessions.

One in 11 Americans has diabetes today, and 86 million more – about one in three – are at risk for developing type 2 diabetes.

The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego June 9 through June 13

The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego this weekend, June 9 through June 13, and Pharmacy Times will bring you all the latest diabetes news from this meeting.

Most experts recommend adding basal insulin, but basalization has its limits controlling glucose in type 2 diabetes.

Patients who were seen at an emergency department had an increased likelihood of diabetic ketoacidosis during the next 14 days.

There are no guidelines to help physicians choose insole stiffness for patients with diabetes.

Top news of the day from across the health care landscape.

Drug interactions can affect the pharmacokinetics or pharmacodynamics of diabetes medications, causing decreased efficacy or increased toxicity.

Teenagers face cognitive, social, and psychological pressures that can interfere with successful diabetes management.

The creation of novel investigational drugs that target a protein receptor found in fat tissue could pave the way for better treatments for type 2 diabetes.

Active ingredients in chili peppers and cannabis help subside gut inflammation, and could lead to new therapies for diabetes and colitis.

Metformin may treat Fragile X syndrome.

Vitamin A and a high-fat diet could lead to a high body mass index.